StockData
Context Therapeutics Inc. logo

Context Therapeutics Inc. (CNTX) income statement

CNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.16−0.01 (-5.10%)

Close on Nov 20, 2026Market cap $14.70MP/E –Yield –

See a number that looks wrong?